mice infected with a live vaccine strain of Candida albicans. At 1 and 4 days postinfection, natural killer (NK) cell-enriched fractions from the spleens of antibody-treated mice displayed a dramatic reduction in 5E6+ lymphocytes and negligible anti-YAC-1 cytotoxic activity in vitro. Nevertheless, the frequency of IFN--producing cells in those fractions was reduced by less than half, on average, by anti-NK-1.1 treatment in vivo. In addition, the antibody-treated and infected mice demonstrated unchanged T helper cell responses, as measured by yeast-specific footpad reactions, resistance to reinfection, occurrence of antibodies of different isotypes, and production in vitro of interleukin-2 (IL-2), IFN-y, IL-4, and IL-10 by CD4+ cells. Therefore, although NK cells may contribute to early IFN-y production in Candida-vaccinated mice, these cells apparently do not play a dominant role in the qualitative development of yeast-specific T helper responses.
Systemic inoculation of mice with the fungus Candida albicans can cause either a fatal disseminated disease or a self-limited infection depending on numerous factors, including genetic background of the mice (22) and nature of the yeast strain used for challenge (7, 8, 21) . In both cases, a strong correlation is found between disease outcome and nature of the predominant T helper (Th) cell response, with healing infection involving a Thl-like pattern of reactivity and nonhealer mice developing a preponderance of Th2 responses (6, 24) . However, alteration of the disease outcome and Th conversion are obtained in healer and nonhealer mice by changing their immune status at the time of infection (20, 23) . We have recently shown that a single injection of an anti-gamma interferon (anti-IFN--y) antibody into healer mice infected with a live vaccine strain (LVS) of C. albicans results in the detection of Th2 responses, alters the early expression of interleukin-4 (IL-4) and IFN-,y messages in CD4+ cells, and prevents the onset of long-lived antifungal protection (20, 21) .
Although these studies demonstrated that IFN--y is crucial in regulating Th subset differentiation in C albicans-infected mice, they did not identify the major cells responsible for the early production of IFN-,y, and both CD4+ and CD4-CD8-cells were found to contribute to the effect (21) . Because natural killer (NK) lymphocytes are known to be activated by C. albicans (9, 10, 29) and may secrete IFN-y in response to microbial pathogens (11) , they could play an important role in the early release of IFN--y that leads to protective immunity.
The purpose of the present study was to examine whether NK cells are required for the production of IFN--y that is essential for the development of Thl-associated protection in mice infected with a C. albicans LVS. By selective depletion through an anti-NK cell antibody, we obtained evidence that these cells did contribute to the early produc-* Corresponding author.
tion of IFN--y, yet their deficiency failed to negate the induction of protective immunity and did not modify the expression of the predominant (Thl) phenotype in healer mice.
MATERIALS AND METHODS
Mice. Inbred C57BL/6 and BALB/c mice were obtained from Charles River Breeding Laboratories, Calco, Milan, Italy. C57BL/6 mice of both sexes, ranging in age from 6 to 8 weeks, were used for the in vivo infection experiments.
Yeasts and infections. The origin and characteristics of the C. albicans highly virulent CA-6 strain and the LVS PCA-2 used in this study have already been described in detail (7, 8, 21) . Yeast cells were grown to stationary phase at 28°C under slight agitation in low-glucose Winge medium composed of 0.2% (wt/vol) glucose and 0.3% (wt/vol) yeast extract (BBL Microbiology Systems, Cockeysville, Md.). After a 24-h culture, cells were harvested by low-speed centrifugation (1,000 x g), washed twice in saline, and diluted to the desired density to be injected intravenously into mice in a volume of 0.5 ml.
In vivo NK cell depletion. The hybridoma line PK136 producing immunoglobulin G2a (IgG2a) monoclonal antibody (MAb) to the NK-1.1 alloantigen (14) (24) , the enzyme was avidinalkaline phosphatase conjugate (Vector Laboratories, Burlingame, Calif.), and the substrate was 5-bromo-4-chloro-3-indolylphosphate-p-toluidine salt (BRL Life Technologies, Gaithersburg, Md.). The results were expressed as the mean number of IFN--y-producing cells per 10 cells, calculated by using replicates of serial twofold dilutions of cells pooled from three mice per group per experiment.
Selection of CD4+ cells, production of culture supernatants containing cytokine activity, and cytokine assays. CD4+ lymphocytes were positively selected from pools of spleen cells by means of a panning procedure using anti-murine CD4 MAb GK1.5 (7, 8, 24) . Supernatants from mixed lymphocyte-Candida cultures were obtained as described previously (23, 24) . IFN--y, IL-2, IL-4, and IL-10 assays, together with the source and characteristics of the anticytokine antibody reagents, have been described previously in detail (22) (23) (24) . Briefly, cell supernatants were tested for their concentration of IFN--y by two-site ELISA using rat antimurine IFN--y MAb R4-6A2 as the primary antibody and biotinylated MAb AN-18.17.24 as the secondary antibody. IL-2 and IL-4 were measured in a colorimetric assay using the HT2 T-lymphocyte line that proliferates in response to either of these cytokines, and MAbs S4B6 (anti-IL-2) and llBl (anti-IL-4), at neutralizing concentrations, were used to establish monospecificity. The IL-10 assay was performed by two-site ELISA using anti-IL-10 MAb SXC-2, biotinylated MAb SXC-1, and peroxidase-labeled streptavidin. All cytokine titers were expressed as units per milliliter, calculated by reference to standard curves constructed with known amounts of recombinant cytokines (22) .
Antibody assay. A micro-ELISA procedure was used to quantitate specific antibodies in the sera of yeast-infected mice (23, 24) . The assay involved coating the microtiter plate wells with CA-6 antigen, adding appropriate dilutions of test antisera (from a pool of two to three mice per group), and a further reaction with alkaline phosphatase-conjugated rabbit anti-mouse IgGl, IgG2a, or IgG2b (Zymed Laboratories) or with biotinylated rat MAb anti-mouse IgE (Sanbio bv Biological Products, Uden, The Netherlands) and then with avidin-alkaline phosphatase conjugate. After addition of the substrate solution, the optical density of triplicate samples was read with an ELISA reader with a 405-nm filter.
DTH assay. A direct assay system for measuring the delayed-type hypersensitivity (DTH) response to cell surface antigens (8, 24) , in which heat-inactivated CA-6 cells (2 x 106/0.04 ml of saline) were inoculated into the footpads of yeast-infected mice, was employed. The DTH reaction was recorded 24 h later by weighing the footpad as a measure of swelling, and results were expressed as the increase in footpad weight over that of the saline-injected counterpart. Data are the means ± the standard errors of eight mice per group.
RESULTS
Effect of NK-1.1 cell depletion on the course of primary candidiasis and resistance to reinfection. In a first series of experiments, C57BV/6 mice, which are known to be genetically resistant to candidiasis (4, 12) , were treated with anti-NK-1.1 antibody starting 1 day before infection with 106 blastoconidia of the LVS PCA-2. Depletion of splenic NK cells was confirmed by cytofluorometric analysis of the 5E6+ subset (Fig. 1A) in nylon wool-nonadherent cells in Percoll fraction 2 and by assessment of anti-YAC-1 cytotoxic potential in vitro (Fig. 1B) . The antibody-treated and infected mice were monitored for mortality parameters, and after 2 weeks survivors were rechallenged with 106 cells of the highly virulent strain CA-6 (Table 1) . It is apparent that the PCA-2-infected mice treated with control or anti-NK-1.1 antibodies resisted primary challenge and developed protective anticandidal immunity, despite the severe impairment in anti-YAC-1 cytotoxic activity resulting from NK cell deficiency. This suggested that the development of protective Thl responses in PCA-2-infected mice might not be modified by anti-NK-1.1 treatment.
Development of Candida-specific footpad reaction. Prior studies have demonstrated a strong correlation between the development of DTH responses and the onset of protective anticandidal immunity in mice vaccinated with a LVS of C. albicans (7, 8, 24) jected intrafootpad with heat-inactivated blastoconidia 1 or 2 weeks after infection. Twenty-four hours later, the increase in footpad weight was measured. Figure 2 shows that the development of a strong DTH reactivity was not affected by the ablation of NK-1.1+ cells.
Effect of MAb treatment on B-cell isotype expression. Because protective anticandidal responses are often concomitant with high DTH expression and either low antibody production or antibodies mostly of the IgG2a isotype (7, 8, 23, 24) , we measured the levels of yeast-specific antibodies in the sera of anti-NK-1.1-treated mice infected with PCA-2 cells. At 1 and 2 weeks after the injection of 105 blastoconidia, sera were collected and assayed for their contents of IgG2a and IgG2b, which are Thl-associated isotypes, or IgGl and IgE, which are Th2-associated isotypes (16) . Figure 3 shows that the ablation of NK-1.1+ cells had no effect on regulation of B-cell isotype expression in vaccinated mice.
Effect of NK-1.1 cell depletion on cytokine production in vitro. The development of Thl and Th2 responses is associated with the detection of different cytokine secretion profiles in vitro, which may account in vivo for most of the (Fig. 5) . The results indicated that, early after LVS infection, the Percoll-fractionated population contained cells producing IFN--y at a frequency of about 1 of 180, largely irrespective of antigen or lectin stimulation. However, in four independent experiments, anti-NK-1.1 treatment was found to decrease the number of IFN--y-secreting cells by an average of 47% (mean frequency, 1 of 336), despite the fact that anti-YAC-1 cytotoxic activity in the same cell fraction was absent or minimal (Fig. 1B) . The greatest reduction (67%) was observed with unstimulated cells 1 day after infection, whereas the lowest reduction (32%) was observed with cells harvested 4 days postinfection upon overnight stimulation with heat-inactivated C. albicans. This suggested that in NK cell-enriched fractions, other cells in addition to NK-1.1-bearing lymphocytes might be producing IFN-y. 
DISCUSSION
The in vivo relevance of NK cells in the mouse resistance to inoculation candidiasis has been studied mostly by examining the course of infection in NK-deficient beige mice versus control heterozygous littermates (1, 3, 5) . However, since the defect in beige mice affects the lytic capacity of NK cells but the frequency of target-binding cells remains unaltered (and so, presumably, nonlytic properties), beige mice may not be an ideal model to investigate all of the biological properties of NK cells, particularly those related to the production of cytokines (reviewed in reference 15). After the demonstration that inoculation of anti-asialo GM1 antiserum almost completely abolishes NK cell activity, this treatment has recently been employed to define the role of NK cells in the susceptibility of severe combined immunodeficient mice to systemic candidiasis (13) (21) .
The ability of NK cells to respond to macrophage-derived factors such as IFN-a and IL-12 and hence release IFN--y, and considering the finding that C albicans is known to activate NK cells (9, 10, 29) , makes NK lymphocytes good candidates for a determining role in CD4+ subset differentiation (19 However, anti-NK-1.1 MAb treatment, which reduced the presence of 5E6+ cells in that fraction to 3% + 2% (day 1) and 1% ± 2% (day 4; Fig. 1A ) and abolished lysis of YAC-1 targets by day 4 (Fig. 1B) , would reduce the frequency of IFN-y-producing cells by only 32 to 67%, depending on the assay conditions. Therefore, although NK cells were activated to produce IFN-y in mice infected with PCA-2, it is likely that only a portion of the early splenic production of IFN--y in vitro could be attributed to NK cells, even in an NK cell-rich fraction. It is interesting to note that Percoll fraction 2 from mice infected with PCA-2 for 1 to 4 days contained as much as 50% CD3+ cells, a percentage that rose to 70% in PK136-treated mice (data not shown). A detailed characterization of these T cells, most of which were CD4-CD8-, will be the subject of a subsequent publication.
Although the present article deals with the effects of anti-NK.1.1+ treatment, a similar study using anti-asialo GM1 antiserum as a means to deplete NK cells has been conducted in parallel. Despite the fact that its specificity for NK cells is questionable, anti-asialo GM1 antiserum is indeed a strong inhibitor of NK cell activity (reviewed in reference 15). By using a single intraperitoneal injection of 400 ,ug of polyclonal rabbit anti-asialo GM1 per mouse administered 24 h before PCA-2 infection, we obtained evidence that the NK cell deficiency caused by this treatment was not associated with impaired anticandidal resistance, changes in CD4 subset expression, or ablation of IFN--y-producing cells in Percoll-fractionated splenic populations from infected mice (data not shown).
In a recent work by Varkila et al. (28) , C.B-17 scid mice, which are very susceptible to infection with Leishmania major, were reconstituted with low numbers of T cells from nonhealer BALB/c mice, which led to a Thl-associated healing response dependent on the host's ability to produce IFN--y. Interestingly, depletion of NK cells from infected, reconstituted scid mice for 3 to 4 days with a single injection of anti-asialo GM1 antiserum did not affect the development of a Thl response. This lack of effect was taken by the authors to indicate either that NK cells did not contribute to IFN--y production in vivo or that NK cells were not depleted for a long enough period of time.
In conclusion, the data of the present article confirm previous observations that NK cells do not play an important role in resistance to candidiasis in mice (1, 2, 13, 30) and are consistent with previous results on the lack of effect of NK cell deficiency on acquired anticandidal resistance as observed in beige mice (5) . In particular, our data demonstrate that NK cells, although activated by C. albicans infection, are not absolutely required for the production of IFN--y that is essential for development of Thl responses in vaccinated mice. The early events in natural anticandidal response and the cellular sources of cytokines that will determine the phenotype of the subsequent specific response remain to be clarified.
